RCM

RA Capital Management Portfolio holdings

AUM $8.12B
1-Year Est. Return 46.06%
This Quarter Est. Return
1 Year Est. Return
+46.06%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.67B
AUM Growth
-$1.54B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
105
New
Increased
Reduced
Closed

Top Buys

1
+$82.4M
2
+$55.9M
3
+$47.2M
4
RLMD icon
Relmada Therapeutics
RLMD
+$45.1M
5
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
+$34.8M

Top Sells

1
+$190M
2
+$35.9M
3
+$21M
4
CTMX icon
CytomX Therapeutics
CTMX
+$17.8M
5
WHWK
Whitehawk Therapeutics
WHWK
+$10.2M

Sector Composition

1 Healthcare 98.88%
2 Financials 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$33.4M 0.59%
2,805,045
52
$32M 0.56%
+2,002,217
53
$26.6M 0.47%
5,914,252
54
$25.5M 0.45%
1,930,322
55
$25.1M 0.44%
5,014,687
56
$25M 0.44%
+2,282,173
57
$24.6M 0.43%
2,250,000
58
$24.4M 0.43%
7,775,207
59
$21.6M 0.38%
824,525
60
$20.1M 0.35%
2,150,404
61
$19.4M 0.34%
2,281,249
62
$16.9M 0.3%
+549,055
63
$16.3M 0.29%
+1,000,000
64
$16.1M 0.28%
444,444
65
$14.7M 0.26%
2,246,503
66
$14.7M 0.26%
1,500,000
67
$14.5M 0.26%
914,094
68
$14.4M 0.25%
1,334,610
-180,541
69
$13.8M 0.24%
2,589,904
70
$13.5M 0.24%
2,691,770
-39,400
71
$13.2M 0.23%
217,710
72
$12.8M 0.23%
969,479
-133,393
73
$12.6M 0.22%
2,436,430
74
$12.3M 0.22%
1,250,000
75
$11.9M 0.21%
+1,857,755
1 2
3
4 5